Activity value 80china Buyer&Supplier,Last transaction date:
2026-04-16
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for qilu synva pharmceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 25 transactions, with a transaction quantity of 57150 and a transaction weight of 13208.
YearTransactionsQuantityWeight
2025151275843.29122544.81
2026255715013208
Bill of lading data
<
1/15
>
Trade date
2026/03/12
B/L No.
108042237110
Suppliers
qilu synva pharmceutical co.ltd.
Buyers
công ty tnhh atona
Product description
Nguyên liệu sản xuất thuốc thú y CEFTIOFUR HYDROCHLORIDE. Số lô 50671363K NSX 30/12/2025_HSD 30/12/2027 Nhà SX Qilu Synva Pharmaceutical Co., Ltd. Hàng mới 100%
Expand
Trade date
2026/03/10
B/L No.
108036679810
Suppliers
qilu synva pharmceutical co.ltd.
Buyers
công ty tnhh lva việt nam
5thanh nhon corp.
vietnambuyer,they trade on 2024-07-10
403.37%
>
+View All
Products
Total 66
ProductsTransactionsPerDetail
ceftriaxone sodium 6031.41%>
entercavir 6031.41%>
neomycin sulphate 6031.41%>
flunixin meglumine 2010.47%>
heterocyclic organic compounds 178.9%>
+View All
Hscode rank
Total 92
HSCode NameTransactionsPerDetail
HS 294190006031.41%>
HS 38089199189.42%>
HS 29333999178.9%>
HS 29419090168.38%>
HS 29333990168.38%>
+View All
Trading Area
Total 13
AreaTransactionsPerDetail
vietnam43936.95%>
mexico18715.74%>
india12510.52%>
turkey11910.02%>
russia978.16%>
+View All
Port statistics
Total 20
Port NameTransactionsPerDetail
qingdao756.31%>
shanghai635.30%>
shanghai cn514.29%>
jinan312.61%>
qingdao china republica popular de161.35%>
+View All
qilu synva pharmceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2026-04-16, the company has completed 1188 international trades,
with its main trading regions covering vietnam,mexico,india etc.
The core products include HS29419000,HS38089199,HS29333999 etc,
often transported via qingdao,port shanghai, port shanghai cn etc,
and its main trading partners are central de productos quimicos de cv,skies,ооо нита фарм.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on qilu synva pharmceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.